"Thrombolysed" means breaking down or dissolving a blot clot.
"Streptokinase" is a drug that is used to break down blot clots.
For example, this may be done to treat a heart attack, where a blot clot is blocking the flow of blood to part of the heart.
Streptokinase and tissue-type plasminogen activator are used for:
Streptokinase and tissue-type plasminogen activator are used for:
Streptokinase and tPA are both thrombolytics, meaning that they break up clots.
FFP i think.
streptococci
Clot buster.
Michael Martin has written: 'Streptokinase in chronic arterial disease' -- subject(s): Arterial occlusions, Arteries, Chemotherapy, Chronic diseases, Stenosis, Streptokinase, Therapeutic use
ECg MONITOR bleeding, bradycardia
It is a Thromolytic used to dissolve blood clots to revive patients during a heart attack. It is the commercial name given to Streptokinase.
The enzyme streptokinase may be given to help dissolve the renal clot. Anticoagulant medications are usually prescribed to prevent clots from recurring.
Both are thrombolyltic drugs. Streptokinase binds to the active complex. It promotes the cleavage of the Arg/Val bond of plasminogen leading to the formation of plasmin. The plasmin then breaks down the matrix of the thrombus. A tissue plasminogen activator is alteplase. It binds to fibrin-rich clots and cleaves the Arg/Val bond of plasminogen to produce plasmin. The plasmin then breaks down the matrix of the thrombus.
In the body's natural systems, tissue plasminogen activator or tPA attaches itself to the clot and breaks it down by plasmin fibrinolysis. This is done artificially (thrombolysis) using drugs such as streptokinase, urokinase, or recombinant tPA formulations.